"The U.S. Food and Drug Administration today approved Pomalyst (pomalidomide) to treat patients with multiple myeloma whose disease progressed after being treated with other cancer drugs.
Multiple myeloma is a form of blood cancer that p"...
Phosphocol® P 32
(chromic phosphate P 32) Suspension
Therapeutic intraperitoneal or intracavitary injection only for treatment of peritoneal or pleural effusions caused by metastatic disease.
Phosphocol® P 32 is supplied as a sterile, nonpyrogenic aqueous suspension in a 30% dextrose solution with 2% benzyl alcohol added as preservative. Each milliliter contains 1 mg sodium acetate. Sodium hydroxide or hydrochloric acid may be present for pH adjustment.
Last reviewed on RxList: 6/17/2009
This monograph has been modified to include the generic and brand name in many instances.
Additional Phosphocol Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options.